Hologic Operating Margin from 2010 to 2024

HOLX Stock  USD 78.97  0.25  0.32%   
Hologic Operating Profit Margin yearly trend continues to be fairly stable with very little volatility. Operating Profit Margin is likely to outpace its year average in 2024.
Check Hologic financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hologic's main balance sheet or income statement drivers, such as Depreciation And Amortization of 324.4 M, Interest Expense of 74.8 M or Total Revenue of 4.2 B, as well as many indicators such as Price To Sales Ratio of 5.0, Dividend Yield of 0.0 or PTB Ratio of 3.56. Hologic financial statements analysis is a perfect complement when working with Hologic Valuation or Volatility modules.
  
Check out the analysis of Hologic Correlation against competitors.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Latest Hologic's Operating Margin Growth Pattern

Below is the plot of the Operating Profit Margin of Hologic over the last few years. It is Hologic's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Hologic's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.24 %10 Years Trend
Slightly volatile
   Operating Profit Margin   
       Timeline  

Hologic Operating Margin Regression Statistics

Arithmetic Mean0.25
Geometric Mean0.24
Coefficient Of Variation32.08
Mean Deviation0.07
Median0.22
Standard Deviation0.08
Sample Variance0.01
Range0.2239
R-Value0.43
Mean Square Error0.01
R-Squared0.18
Significance0.11
Slope0.01
Total Sum of Squares0.09

Hologic Operating Margin History

2024 0.23
2023 0.22
2022 0.17
2016 0.34
2011 0.19
2010 0.11

About Hologic Financial Statements

Hologic investors use historical fundamental indicators, such as Hologic's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Hologic. Please read more on our technical analysis and fundamental analysis pages.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for womens health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts. Hologic operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 6705 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.